What if NVS/MNTA Copaxone is non-infringing, but MYL/Natco’s Copaxone does infringe? Wouldn’t that complicate the Court’s dealings with respect to the non-infringement argument?
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”